Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
- Status
- UNKNOWN
- Phase
- N/A
Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Hypertension in Breast Cancer Patients Receiving Bevacizumab
- Status
- TERMINATED
- Phase
- N/A
Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- NA
Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Pilot Weight Control Intervention at HPHC
- Status
- COMPLETED
- Phase
- NA
Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Improving Outcomes Assessment in Chronic GVHD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host Disease
- Status
- COMPLETED
- Phase
- N/A
In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer
- Status
- COMPLETED
- Phase
- PHASE1
RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease
- Status
- COMPLETED
- Phase
- NA
Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1